tailieunhanh - Mutation landscape of germline and somatic BRCA1/2 in patients with highgrade serous ovarian cancer

Poly (ADP-ribose) polymerase inhibitors targeting BRCA1/2 mutations are available for treating patients with high-grade serous ovarian cancer. These treatments may be more appropriately directed to patients who might respond if the tumor tissue is additionally tested by next-generation sequencing with a multi-gene panel and Sanger sequencing of a blood sample. | Mutation landscape of germline and somatic BRCA1 2 in patients with highgrade serous ovarian cancer

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN